{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 412253910
| IUPAC_name = 3-Methoxy-6α-hydroxy-4,5α-epoxy-7,8-didehydromorphinan
| image = Norcodeine.svg
| width = 180
<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = Schedule I
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = 
| legal_DE = Anlage I
| routes_of_administration = 
<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 467-15-2
| ATC_prefix = none
| ATC_suffix = 
| PubChem           = 9925873
| DrugBank          = 
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 8101508
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 32W9P3T4ML
<!--Chemical data-->
| C=17 | H=19 | N=1 | O=3
| molecular_weight = 285.337 g/mol
| synonyms = 
| smiles            = COC1=C2C3=C(C[C@@H]4[C@H]5[C@]3(CCN4)[C@@H](O2)[C@H](C=C5)O)C=C1
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C17H19NO3/c1-20-13-5-2-9-8-11-10-3-4-12(19)16-17(10,6-7-18-11)14(9)15(13)21-16/h2-5,10-12,16,18-19H,6-8H2,1H3/t10-,11+,12-,16-,17-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = HKOIXWVRNLGFOR-KOFBORESSA-N
}}

{{Distinguish|Norco (medication)}}

'''Norcodeine''' is an [[opiate]] [[structural analog|analogue]] that is the N-demethylated derivative of [[codeine]]. It has relatively little [[opioid]] activity in its own right,<ref>Fraser HF, Isbell H, Van Horn GD. Human pharmacology and addiction liability of norcodeine. ''Journal of Pharmacology and Experimental Therapeutics''. 1960 Jun;129:172-7. {{PMID|13824628}}</ref> but is formed as a metabolite of codeine following ingestion.<ref>Posey BL, Kimble SN. High-performance liquid chromatographic study of codeine, norcodeine, and morphine as indicators of codeine ingestion. ''Journal of Analytical Toxicology''. 1984 Mar-Apr;8(2):68-74. {{PMID|6716978}}.</ref>

Norcodeine is a Schedule I Narcotic controlled substance in the USA with the ACSCN of 9309 and zero annual manufacturing quota.  The salts in use are the acetate (free base conversion ratio 0.826), hydroiodide (0.662), hydrochloride (0.759), nitrate (0.819), platinichloride (0.582), and sulphate (0.744).<ref>http://www.deadiversion.usdoj.gov/fed_regs/quotas/2014/fr0825.htm</ref>

==See also==
* [[Nalodeine]]

==References==
{{Reflist|2}}


{{Opioidergics}}

[[Category:Morphinans]]
[[Category:Phenol ethers]]
[[Category:Alcohols]]
[[Category:Opiates]]
[[Category:Opioid metabolites]]


{{Nervous-system-drug-stub}}